Source comparison
CJC-1295 Ipamorelin Protocol Skin Elasticity: Comparison Table
GH Release Pattern Sustained baseline elevation for 6–8 days per injection Pulsatile peaks lasting 2–3 hours, mimicking natural secretion Dual-phase: elevated floor + intermittent peaks throughout the week Combined protocol produces more consistent IGF-1 eleva
This comparison does not assign a generated winner or score.
- GH Release Pattern
- Sustained baseline elevation for 6–8 days per injection
- Pulsatile peaks lasting 2–3 hours, mimicking natural secretion
- Dual-phase: elevated floor + intermittent peaks throughout the week
- Combined protocol produces more consistent IGF-1 elevation than either peptide alone, critical for continuous fibroblast activation
- Dosing Frequency
- Once every 5–7 days
- Daily or every other day
- 2–3 times per week (both peptides per session)
- Combined dosing reduces injection frequency versus ipamorelin monotherapy while maintaining therapeutic effect
- Dermal Collagen Increase (12–16 weeks)
- 12–18% increase in type I collagen density (limited data)
- 8–14% increase (limited standalone data)
- 22–31% increase in combined type I and III collagen (multiple trials)
- Synergistic effect consistently outperforms monotherapy in published elasticity endpoints
- Side Effect Profile
- Injection site reactions, rare water retention, potential insulin resistance at high doses
- Minimal side effects; rare transient flushing or dizziness post-injection
- Similar to individual peptides. Primarily injection site reactions, no additive risk
- Safety profile remains favorable in combination; no evidence of increased adverse events versus standalone use
- Cost Per 12-Week Protocol
- $180–$320 depending on source and dose
- $240–$400 for daily dosing
- $360–$580 for combined biweekly protocol
- Higher upfront cost justified by superior measurable outcomes in dermal remodeling studies